These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 17209522)
1. New strategies to improve the efficacy of colorectal cancer vaccines: from bench to bedside. Mocellin S Curr Opin Investig Drugs; 2006 Dec; 7(12):1052-61. PubMed ID: 17209522 [TBL] [Abstract][Full Text] [Related]
3. Cancer vaccine development: on the way to break immune tolerance to malignant cells. Mocellin S; Rossi CR; Nitti D Exp Cell Res; 2004 Oct; 299(2):267-78. PubMed ID: 15350526 [TBL] [Abstract][Full Text] [Related]
4. Immunotherapy for metastatic colorectal cancer: present status and new options. Ellebaek E; Andersen MH; Svane IM; Straten PT Scand J Gastroenterol; 2012 Mar; 47(3):315-24. PubMed ID: 22214467 [TBL] [Abstract][Full Text] [Related]
5. Towards therapeutic vaccines for colorectal carcinoma: a review of clinical trials. Mosolits S; Nilsson B; Mellstedt H Expert Rev Vaccines; 2005 Jun; 4(3):329-50. PubMed ID: 16026248 [TBL] [Abstract][Full Text] [Related]
6. Advances in specific immunotherapy for prostate cancer. Kiessling A; Füssel S; Wehner R; Bachmann M; Wirth MP; Rieber EP; Schmitz M Eur Urol; 2008 Apr; 53(4):694-708. PubMed ID: 18061335 [TBL] [Abstract][Full Text] [Related]
8. Vaccination therapy with tumor-dendritic cell hybrids: a promising therapeutic approach? Haenssle HA Curr Opin Investig Drugs; 2005 Dec; 6(12):1240-5. PubMed ID: 16370389 [TBL] [Abstract][Full Text] [Related]
9. Active specific immunotherapy for colorectal cancer. Indar AA; Maxwell-Armstrong CA Expert Rev Anticancer Ther; 2003 Oct; 3(5):685-94. PubMed ID: 14599091 [TBL] [Abstract][Full Text] [Related]
10. [Trends in colorectal cancer vaccination]. Mocellin S; Campana LG Recenti Prog Med; 2005; 96(7-8):338-43. PubMed ID: 16209113 [TBL] [Abstract][Full Text] [Related]
11. Cancer vaccines for established cancer: how to make them better? Andrews DM; Maraskovsky E; Smyth MJ Immunol Rev; 2008 Apr; 222():242-55. PubMed ID: 18364006 [TBL] [Abstract][Full Text] [Related]
13. Therapeutics targeting tumor immune escape: towards the development of new generation anticancer vaccines. Mocellin S; Nitti D Med Res Rev; 2008 May; 28(3):413-44. PubMed ID: 17694549 [TBL] [Abstract][Full Text] [Related]